Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?I Vaz-Luis, E P Winer, N U LinAnnals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2011
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancerE M Olson, N U Lin, P J DiPiro, et al.Oncogene|October 27, 2015
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancersQ Wang, P Liu, J M Spangle, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorshipK J Ruddy, E P WinerOncology (Williston Park, N.Y.)|November 27, 1998
Oral 5-FU analogues in the treatment of breast cancerC A Bunnell, E P WinerOncology (Williston Park, N.Y.)|January 1, 1994
Quality of life after bone marrow transplantationE P Winer, L M SuttonOncology|November 6, 2001
New combinations with Herceptin in metastatic breast cancerE P Winer, H J BursteinSeminars in Oncology|September 12, 2001
Liposomal anthracyclines for breast cancerJ A Sparano, E P WinerPageof 12